Publications by authors named "Andrew Ferree"

Claim this Profile
C
Cathepsin Oxidation Alters Alpha-Synuclein Processing.
Andrew W Ferree

Front Neurol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime induced neurotoxicity: A case series and review of the literature.
Cigdem Isitan, Andrew Ferree, Anna DePold Hohler

eNeurologicalSci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MitoTimer probe reveals the impact of autophagy, fusion, and motility on subcellular distribution of young and old mitochondrial protein and on relative mitochondrial protein age.
Andrew W Ferree, Kyle Trudeau, Eden Zik, Ilan Y Benador, Gilad Twig

Autophagy· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.
Fabio Di Domenico, Rukhsana Sultana, Andrew Ferree, Katelyn Smith, Eugenio Barone

Antioxid Redox Signal· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dynamics: the intersection of form and function.
Andrew Ferree, Orian Shirihai

Adv Exp Med Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of physiologic actions of LRRK2: focus on autophagy.
Andrew Ferree, Maria Guillily, Hu Li, Katelyn Smith, Aki Takashima

Neurodegener Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Watching worms whither: modeling neurodegeneration in C. elegans.
Benjamin Wolozin, Christopher Gabel, Andrew Ferree, Maria Guillily, Atsushi Ebata

Prog Mol Biol Transl Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.
Cindy H Hsu, Diane Chan, Elisa Greggio, Shamol Saha, Maria D Guillily, Andrew Ferree

J Neurochem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.
Shamol Saha, Maria D Guillily, Andrew Ferree, Joel Lanceta, Diane Chan

J Neurosci· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating convergent actions of genes linked to familial Parkinson's disease.
Benjamin Wolozin, Shamol Saha, Maria Guillily, Andrew Ferree, Misha Riley

Neurodegener Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations.
Eva Hedlund, Jan Pruszak, Andrew Ferree, Angel Viñuela, Sunghoi Hong

Stem Cells· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells.
Dong-Wook Kim, Sangmi Chung, Mikyeong Hwang, Andrew Ferree, Hsing-Chen Tsai

Stem Cells· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease.
Rosario Sánchez-Pernaute, Andrew Ferree, Oliver Cooper, Meixiang Yu, Anna-Liisa Brownell

J Neuroinflammation· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
Hyemyung Seo, Andrew W Ferree, Ole Isacson

Eur J Neurosci· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis